AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
3.560
+0.190 (5.64%)
Oct 20, 2026, 4:00 PM EDT - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $134.34 million as of October 20, 2026. It is the 23,281st most valuable company in the world and the 3,885th biggest in the United States. Its market cap has increased by 313.13% in one year.
Market Cap
134.34M
Enterprise Value
55.95M
1-Year Change
313.13%
Global Rank
Country Rank
#3,885 United States
Category
ChartMarket Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $134.34M, a decrease of -52.21%. That is a compound annual growth rate of -14.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 134.34M | 330.05% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 142.11M |
| Molecular Partners AG | 141.62M |
| Korro Bio | 139.01M |
| Jyong Biotech | 138.07M |
| Canton Strategic Holdings | 137.85M |
| Atrium Therapeutics | 136.50M |
| Voyager Therapeutics | 134.94M |
| Retension Pharmaceuticals | 134.81M |